BLSM · NASDAQ · Healthcare · $437.0M
$13.75-9.6%vs prev closeclose of 2026-10-30 · not real-time
⚠ Value-trap warning
This stock is flagged by our value-trap filter (e.g. shrinking earnings, negative free cash flow, or losses). Cheap can stay cheap — read why before acting.
Which value-trap type
vs. analyst consensus target. The target is an opinion, not a prediction or buy signal.
Some axes lack data (–)
A summary of valuation factors — not a buy recommendation. You decide.
| Company | PER | PBR | ROE | Div | Score |
|---|---|---|---|---|---|
| BlossomHill Therapeutics Inc. | – | – | – | 0.0% | 35 |
| CorMedix Inc. | 2.8 | 1.0 | 55% | 0.0% | 72 |
| Kamada Ltd. | 20.3 | 1.7 | 8% | 2.1% | 72 |
| BrainsWay Ltd. | 49.4 | 5.8 | 13% | 0.0% | 44 |
| Delcath Systems Inc. | – | 4.0 | 0% | 0.0% | 40 |
| TRex Bio Inc. | – | – | – | 0.0% | – |
Same sector, nearest by market cap · – = no data (value traps excluded)
Open-market buys & sells by this company's officers & directors (SEC Form 4)
Observational — buy/sell facts only, not a recommendation. Filing dates (the trade was 1–2 business days earlier). Routine comp (option exercises, grants) excluded — discretionary buys/sells only.
The chart (long-term trend, Ichimoku cloud) is for observation only — not a buy or sell signal.
A highlight of the key metrics detailed below.
Top-tier in 0 of 1 evaluated strategies
Ranks within the US market — tap to open that ranking (ranks are per market).
Past returns — they do not guarantee future results.
Color: green = healthy, red = caution (absolute thresholds, value/quality metrics only). Downside vol & Sortino are annualized. Max drawdown = largest drop from a 3-year peak; volatility = 1-year annualized. Price/Graham < 1 = below Graham fair value (profitable, positive-equity names only). RSI < 30 = oversold. For reference only.
A Japanese trend tool. Price above the 'cloud' is supportive; below is weak. A strong uptrend doesn't mean it's cheap — stocks that have run up are usually more expensive.